The identified cohesin mutations in AML patients are typically classified in two categories: mutations in RAD21 and STAG2 are mainly truncation or frame-shift while mutations in SMC3 and SMC1A are mainly missense (Kon et al., 2013; Thota et al., 2014). The gene discussed is RAD21; the disease is acute myeloid leukemia.